Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1998 | |
| Cash Flows From Operating Activities | |
| Net Income | 20 |
| Depreciation Amortization | 60 |
| Other Working Capital | -700 |
| Operating Cash Flow | $-620 |
| Cash Flows From Investing Activities | |
| PPE Investments | -210 |
| Other Investing Activity | -80 |
| Investing Cash Flow | $-290 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 10 |
| Financing Cash Flow | $10 |
| Beginning Cash Position | 28,020 |
| End Cash Position | 27,120 |
| Net Cash Flow | $-900 |
| Free Cash Flow | |
| Operating Cash Flow | -620 |
| Free Cash Flow | -620 |